EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracapsular Extension Does Not Decrease Overall Survival in Rectal Cancer Patients with Lymph Node Metastasis Following Neoadjuvant Chemoradiotherapy

Leonardo Lino-Silva, Carmen Sánchez-Acosta, Rosa Salcedo-Hernández, César Zepeda-Najar

Gastroenterology Insights · 2020

DOI: 10.3390/gastroent11020004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Insights, 2020. Verfasst von Leonardo Lino-Silva und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Tumor-Node-Metastasis system does not include additional prognostic factors present in the Lymph Node Metastasis (LNM) such as extra-capsular extension (ECE), which is associated with decreased survival. There are not studies addressing this topic in rectal cancer patients with preoperative chemoradiotherapy (nCRT) and total mesorectal excision (TME).

Aim

We aimed to examine the survival influence of ECE in patients with stage III rectal cancer who received nCRT followed by surgery.

Methods

A retrospective study of 126 patients prospectively collected with rectal cancer in clinical stage III rated with nCRT and TME from 2010 to 2015 was performed.

Results

In total, 71.6% of cases had 1 to 3 lymph node metastases, most tumors were grade 2 (52.4%), 25.4% had good pathologic response, 77.8% had a good quality TME, and the median tumor budding count was 4/0.785 mm2. Forty-four (34.9%) patients had ECE+, which was associated with a higher nodal stage (pN2), perineural invasion and a higher lymph node retrieval. The factors associated with the survival were a higher pathologic T stage, higher pathological N stage, high-grade tumors, and perineural invasion. The ECE did not decrease the 5–year survival with a similar median survival (86.5 months for the ECE+ group vs. 84.1 for the ECE–).

Conclusion

Our results demonstrate that ECE has no impact on overall survival in rectal cancer patients who received nCRT and this was independent of nodal stage or number of lymph nodes examined.

Zitieren

APA

Lino-Silva, L., Sánchez-Acosta, C., Salcedo-Hernández, R., & Zepeda-Najar, C. (2020). Extracapsular Extension Does Not Decrease Overall Survival in Rectal Cancer Patients with Lymph Node Metastasis Following Neoadjuvant Chemoradiotherapy. Gastroenterology Insights. https://doi.org/10.3390/gastroent11020004

Vancouver

Lino-Silva L, Sánchez-Acosta C, Salcedo-Hernández R, Zepeda-Najar C. Extracapsular Extension Does Not Decrease Overall Survival in Rectal Cancer Patients with Lymph Node Metastasis Following Neoadjuvant Chemoradiotherapy. Gastroenterology Insights. 2020. doi:10.3390/gastroent11020004

BibTeX
@article{LinoSilva2020,
  author = {Lino-Silva, Leonardo and Sánchez-Acosta, Carmen and Salcedo-Hernández, Rosa and Zepeda-Najar, César},
  title = {Extracapsular Extension Does Not Decrease Overall Survival in Rectal Cancer Patients with Lymph Node Metastasis Following Neoadjuvant Chemoradiotherapy},
  journal = {Gastroenterology Insights},
  year = {2020},
  doi = {10.3390/gastroent11020004}
}
Kostenlos starten →